187 related articles for article (PubMed ID: 25128062)
1. Over-expression of TRPM8 is associated with poor prognosis in urothelial carcinoma of bladder.
Xiao N; Jiang LM; Ge B; Zhang TY; Zhao XK; Zhou X
Tumour Biol; 2014 Nov; 35(11):11499-504. PubMed ID: 25128062
[TBL] [Abstract][Full Text] [Related]
2. Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder.
Du E; Zhang C; Qin Z; Yang K; Li C; Wang A; Zhang Z; Xu Y
Urol Oncol; 2017 Apr; 35(4):152.e7-152.e12. PubMed ID: 28161324
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder.
Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K
Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.
Liu JY; Li YH; Lin HX; Liao YJ; Mai SJ; Liu ZW; Zhang ZL; Jiang LJ; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
BMC Cancer; 2013 Jul; 13():349. PubMed ID: 23870412
[TBL] [Abstract][Full Text] [Related]
5. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
Zhu J; Lu Z; Ke M; Cai X
Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.
Yan Y; Yang FQ; Zhang HM; Li J; Li W; Wang GC; Che JP; Zheng JH; Liu M
Int J Clin Exp Pathol; 2014; 7(7):4231-8. PubMed ID: 25120803
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of miR-222 is associated with poor prognosis in bladder cancer.
Zhang DQ; Zhou CK; Jiang XW; Chen J; Shi BK
World J Surg Oncol; 2014 Jul; 12():241. PubMed ID: 25078265
[TBL] [Abstract][Full Text] [Related]
8. Increased SPHK1 expression is associated with poor prognosis in bladder cancer.
Meng XD; Zhou ZS; Qiu JH; Shen WH; Wu Q; Xiao J
Tumour Biol; 2014 Mar; 35(3):2075-80. PubMed ID: 24092575
[TBL] [Abstract][Full Text] [Related]
9. Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder.
Yang FQ; Huang JH; Liu M; Yang FP; Li W; Wang GC; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(1):340-7. PubMed ID: 24427355
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
11. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
[TBL] [Abstract][Full Text] [Related]
13. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
Wang S; Li Q; Wang K; Dai Y; Yang J; Xue S; Han F; Zhang Q; Liu J; Wu W
Clin Transl Oncol; 2013 Oct; 15(10):849-54. PubMed ID: 23408039
[TBL] [Abstract][Full Text] [Related]
15. Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer.
Du JD; Zheng X; Chen YL; Huang ZQ; Cai SW; Jiao HB; Zhu ZM; Hu B
Med Sci Monit; 2018 Jun; 24():3720-3725. PubMed ID: 29860264
[TBL] [Abstract][Full Text] [Related]
16. PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.
Liu JY; Qian D; He LR; Li YH; Liao YJ; Mai SJ; Tian XP; Liu YH; Zhang JX; Kung HF; Zeng YX; Zhou FJ; Xie D
Mol Cancer; 2013 Nov; 12(1):148. PubMed ID: 24268029
[TBL] [Abstract][Full Text] [Related]
17. Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance.
Fu Y; Zhao H; Li XS; Kang HR; Ma JX; Yao FF; Du N
Tumour Biol; 2014 Nov; 35(11):11283-7. PubMed ID: 25117073
[TBL] [Abstract][Full Text] [Related]
18. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y
J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374
[TBL] [Abstract][Full Text] [Related]
19. Nucleobindin 2 expression is an independent prognostic factor for bladder cancer.
Cho JM; Moon KT; Lee HJ; Shin SC; Choi JD; Kang JY; Yoo TK
Medicine (Baltimore); 2020 Mar; 99(13):e19597. PubMed ID: 32221080
[TBL] [Abstract][Full Text] [Related]
20. Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.
Hussien MT; Helmy E; Elsaba TM; Elkady A; Alrefai H; Hetta HF
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1573-1583. PubMed ID: 32592351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]